Misonix Inc (MSON) 6.25 $MSON BoneScalpel® Hands-On

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Misonix Inc (MSON) 6.25 $MSON

BoneScalpel® Hands-On Workshop Draws More Than 30 Surgeons at IMAST 2016 Meeting
PR Newswire - Mon Jul 18, 10:12AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, hosted a successful BoneScalpel Hands-On Workshop during the International Meeting on Advanced Spine Technologies ("IMAST" in Washington, DC last week. More than 30 surgeons attended the workshop and were trained on advanced spine surgical techniques utilizing the BoneScalpel.
MSON: 6.25 (+0.03)

Misonix SonicVac(TM) Recognized as a Top Innovation for Wound Care in Podiatry
PR Newswire - Tue Jul 12, 9:02AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced its recently launched product, SonicVac(TM), has been recognized by Podiatry Today as one of the "Top 10 Innovations in Podiatry for 2016." Podiatry Today, an award-winning publication devoted to practicing podiatric professionals, lists the SonicVac in their July edition as an innovation that can spur wounds toward healing with the unique combination of ultrasound and aspiration.
MSON: 6.25 (+0.03)

Misonix Down 44.7% Since SmarTrend Downtrend Call (MSON)
Comtex SmarTrend(R) - Tue Jun 07, 12:53PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 7 months, Misonix has returned 44.74% as of today's recent price of $5.17.
MSON: 6.25 (+0.03)

BoneScalpel® Featured in the Lecture and Workshop at 9th Congress of the Chinese Association of Orthopedic Surgeons Meeting
PR Newswire - Tue May 24, 6:30AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that the BoneScalpel was featured in a presentation before the Congress of the Chinese Association of Orthopedic Surgeons Meeting this week in Chengdu, China. Additionally, Misonix participated in the Master Techniques in Spine Surgery Workshop on May 20, 2016 at the PARTI Center, Huashan Hospital, Fudan University and Chengdu International Exhibition and Convention Center located in Shanghai. This workshop was jointly planned by the Chinese Association of Orthopaedic Surgeons (CAOS) and The North American Spine Society (NASS).
MSON: 6.25 (+0.03)

BoneScalpel to be Featured at Master Techniques in Spine Surgery Workshop at Upcoming Ninth Congress of the Chinese Association of Orthopedic Surgeons Meeting
PR Newswire - Wed May 18, 6:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that it will be participating in the Master Techniques in Spine Surgery Workshop on May 20, 2016 at the PARTI Center, Huashan Hospital, Fudan University and Chengdu International Exhibition and Convention Center (CIECC) located in Shanghai and Chengdu China respectively.
MSON: 6.25 (+0.03)

Misonix Features New BoneScalpel® MIS at SpineWeek 2016 In Singapore
PR Newswire - Mon May 16, 1:26PM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that it will be exhibiting at the 2016 SpineWeek conference in Singapore, to take place from May 16 to May 20, 2016.
MSON: 6.25 (+0.03)

Downtrend Call Working As Misonix Stock Falls 43.8% (MSON)
Comtex SmarTrend(R) - Fri May 06, 1:02PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 43.79% as of today's recent price of $5.26.
MSON: 6.25 (+0.03)

Misonix reports 3Q loss
Automated Insights - Thu May 05, 5:02PM CDT
FARMINGDALE, N.Y. (AP) _ Misonix Inc. (MSON) on Thursday reported a fiscal third-quarter loss of $679,000, after reporting a profit in the same period a year earlier.
MSON: 6.25 (+0.03)

Misonix, Inc. Announces Third Quarter and Nine-Months 2016 Financial Results
PR Newswire - Thu May 05, 3:01PM CDT
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the third quarter and the nine-months of fiscal year 2016 ended March 31, 2016.
MSON: 6.25 (+0.03)

37.7% Return Seen to Date on SmarTrend Misonix Call (MSON)
Comtex SmarTrend(R) - Fri Apr 29, 12:49AM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 37.68% as of today's recent price of $5.83.
MSON: 6.25 (+0.03)

Misonix Has Returned 37.4% Since SmarTrend Recommendation (MSON)
Comtex SmarTrend(R) - Thu Apr 21, 1:18PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 6 months, Misonix has returned 37.36% as of today's recent price of $5.86.
MSON: 6.25 (+0.03)

Misonix Shares Down 33.8% Since SmarTrend's Sell Call (MSON)
Comtex SmarTrend(R) - Wed Apr 06, 1:08PM CDT
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 5 months, Misonix has returned 33.83% as of today's recent price of $6.19.
MSON: 6.25 (+0.03)

Misonix Launches New Vacuum Assisted Ultrasonic Wound Debridement Technology at Diabetic Limb Salvage Conference in Washington D.C.
PR Newswire - Mon Apr 04, 7:45AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced the launch of its newest addition to the SonicOne® platform, SonicVac(TM). This is the first time that the removal of debris and infected tissues is combined with ultrasonic wound debridement.
MSON: 6.25 (+0.03)

Four Clinical Abstracts Demonstrate the Effectiveness of SonicOne® O.R. in Wound Treatment
PR Newswire - Fri Apr 01, 7:00AM CDT
Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced four clinical abstract presentations were made at the 2016 Diabetic Limb Salvage Conference in Washington, D.C. The conference is taking place from March 31 through April 2, 2016. The new data demonstrated the value in using ultrasonic technology in debriding wounds.
MSON: 6.25 (+0.03)

Misonix Supports Belize Spine Surgery Mission
PR Newswire - Wed Mar 16, 1:25PM CDT
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, laparoscopic surgery and other surgical applications, has donated a Bone Scalpel® unit to Spine Overseas for mission work at the Karl Heusner Memorial Hospital in Belize.
MSON: 6.25 (+0.03)

Misonix Has Returned 28.1% Since SmarTrend Recommendation (MSON)
Comtex SmarTrend(R) - Wed Feb 10, 5:23PM CST
SmarTrend identified a Downtrend for Misonix (NASDAQ:MSON) on November 6th, 2015 at $9.36. In approximately 3 months, Misonix has returned 28.06% as of today's recent price of $6.73.
MSON: 6.25 (+0.03)

Misonix posts 2Q profit
Automated Insights - Tue Feb 09, 4:05PM CST
FARMINGDALE, N.Y. (AP) _ Misonix Inc. (MSON) on Tuesday reported fiscal second-quarter net income of $175,000.
MSON: 6.25 (+0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 74

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 13

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 11

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 6

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 5

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 12

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Clinch Scores Big with Two Prestigious Industry Honors

Updated Category News Views 14

Clinch's Dual Triumph in Advertising Innovation No one throws a ticker symbol over their cereal for recognizing brilliance, but when an outfit like Clinch gets double applause at the big dance, even we old-timers have to tip our hats. On November 16, 2026, the advertising world saw some fireworks. Clinch took home not one but two hefty awards—the kind that say you've...

Continue Reading
Parallels Desktop Tops 2026 Picks for Windows on Mac

Updated Category News Views 28

Diving into the Cross-Platform Conundrum Now, I've been in the trenches long enough to know that when companies start relying on Mac computers but can't ditch their essential Windows apps, they're bound to hit a digital brick wall. Picture this—accounting, enterprise management, all that jazz that still needs Windows to function. For those jumping between these two...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 64

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating 40 Years: The Evolution of Fudan SoM

Updated Category News Views 275

Fudan SoM Celebrates a Milestone in Business Education The Fudan University School of Management recently celebrated its 40th anniversary with great enthusiasm, showcasing a commitment to fostering global business education. This significant event coincided with the launch of the 2025 Global Business Education Deans' Forum and Expo, a pivotal gathering that highlights...

Continue Reading
ICU Medical Stock Hits Record Low: What Investors Should Know

Updated Category News Views 321

ICU Medical Faces Significant Market Challenges Amidst a turbulent market landscape, ICU Medical (NASDAQ: ICUI) has witnessed its stock price decline to a 52-week low of $1.69, resulting in a market capitalization plummeting to approximately $7.65 million. The company’s substantial dip in value, which is around -86.22% over the past year, highlights a significant...

Continue Reading
Sagimet Biosciences Unveils Comprehensive Financial Results and Milestones

Updated Category News Views 178

Sagimet Biosciences Shares 2024 Financial Highlights Sagimet Biosciences Inc. (NASDAQ: SGMT), a prominent clinical-stage biopharmaceutical firm focusing on innovative therapies for metabolic and fibrotic disorders, recently revealed its financial outcomes for the full year ended December 31, 2024. With notable advancements in their drug pipeline, Sagimet is...

Continue Reading
Exploring the Expanding Opportunities in Cannabidiol Market

Updated Category News Views 158

Cannabidiol Market Growth Projections The global cannabidiol (CBD) market is a rapidly evolving sector that is transforming the healthcare landscape. With increasing recognition of its therapeutic potential, the market was valued at approximately USD 8.97 billion in 2024 and is set to reach an impressive USD 38.97 billion by 2034. This remarkable growth, projected at a...

Continue Reading
Kelley Morris Appointed President of Hospital Foundations

Updated Category News Views 476

Kelley Morris Steps into Leadership Role The Memorial and Joe DiMaggio Children's Hospital Foundations have made a significant change in leadership by appointing Kelley Morris, MHA, as President and CEO. With an impressive background spanning over 25 years in healthcare philanthropy, operations, and research administration, Morris is set to lead the Foundations in...

Continue Reading